Aspirin
What's New
Last Posted: Apr 22, 2021
- Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?
Biltaji Eman et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021 - Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.
Bakshi Andrew et al. Journal of the National Cancer Institute 2021 4 - Low-dose aspirin and mesalazine for patients with familial adenomatous polyposis.
Lynch Patrick M et al. The lancet. Gastroenterology & hepatology 2021 - The prediction of preeclampsia: the way forward.
Myatt Leslie et al. American journal of obstetrics and gynecology 2021 - Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
Wang Kai et al. Journal of the National Cancer Institute 2021 - The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan Neil A J et al. PLoS medicine 2020 Sep 17(9) e1003263 - Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals.
Lacaze Paul et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jul - Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy.
Pastorino Roberta et al. PloS one 2020 15(7) e0235038 - Aspirin for Lynch syndrome: a legacy of prevention.
Yurgelun Matthew B et al. Lancet (London, England) 2020 395(10240) 1817-1818 - Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Burn John et al. Lancet (London, England) 2020 Jun 395(10240) 1855-1863
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
- CDC Information (2)
- NIH Information (4)
- COVID-19 (9)
- Human Genome Epidemiologic Studies (550)
- GWAS Studies (3)
- Human Genomics Translation/Implementation Studies (22)
- Genomic Tests Evidence Synthesis (19)
- Genomic Tests Guidelines (2)
- Non-Genomics Precision Health (1)
- State Public Health Genomics Programs (2)
- Reviews/Commentaries (36)
- Tools/Methods (1)
- Ethical/Legal and Social Issues (ELSI) (1)
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source: